Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania. more
Time Frame | WST | Sector | S&P500 |
---|---|---|---|
1-Week Return | 2.23% | -3.39% | -3.47% |
1-Month Return | 5.89% | -3.25% | -0.29% |
3-Month Return | 5.22% | -11.61% | 4.5% |
6-Month Return | 1.01% | -5.89% | 6.91% |
1-Year Return | -8.67% | 2.65% | 23.79% |
3-Year Return | -25.9% | 0.56% | 28.43% |
5-Year Return | 117.9% | 34.63% | 83.64% |
10-Year Return | 490.63% | 94.78% | 185.94% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 1.84B | 2.15B | 2.83B | 2.89B | 2.95B | [{"date":"2019-12-31","value":62.37,"profit":true},{"date":"2020-12-31","value":72.78,"profit":true},{"date":"2021-12-31","value":95.99,"profit":true},{"date":"2022-12-31","value":97.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 1.23B | 1.38B | 1.66B | 1.75B | 1.82B | [{"date":"2019-12-31","value":67.79,"profit":true},{"date":"2020-12-31","value":75.75,"profit":true},{"date":"2021-12-31","value":90.95,"profit":true},{"date":"2022-12-31","value":96.16,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 605.70M | 767.80M | 1.18B | 1.14B | 1.13B | [{"date":"2019-12-31","value":51.51,"profit":true},{"date":"2020-12-31","value":65.3,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.63,"profit":true},{"date":"2023-12-31","value":96.04,"profit":true}] |
Gross Margin | 32.92% | 35.76% | 41.52% | 39.36% | 38.28% | [{"date":"2019-12-31","value":79.28,"profit":true},{"date":"2020-12-31","value":86.13,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.78,"profit":true},{"date":"2023-12-31","value":92.19,"profit":true}] |
Operating Expenses | 311.60M | 360.90M | 423.50M | 402.20M | 454.00M | [{"date":"2019-12-31","value":68.63,"profit":true},{"date":"2020-12-31","value":79.49,"profit":true},{"date":"2021-12-31","value":93.28,"profit":true},{"date":"2022-12-31","value":88.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 296.60M | 406.90M | 752.30M | 734.00M | 676.00M | [{"date":"2019-12-31","value":39.43,"profit":true},{"date":"2020-12-31","value":54.09,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.57,"profit":true},{"date":"2023-12-31","value":89.86,"profit":true}] |
Total Non-Operating Income/Expense | (9.50M) | (12.40M) | (10.60M) | (56.90M) | 41.00M | [{"date":"2019-12-31","value":-23.17,"profit":false},{"date":"2020-12-31","value":-30.24,"profit":false},{"date":"2021-12-31","value":-25.85,"profit":false},{"date":"2022-12-31","value":-138.78,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | 291.80M | 401.30M | 748.90M | 679.90M | 698.00M | [{"date":"2019-12-31","value":38.96,"profit":true},{"date":"2020-12-31","value":53.59,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":90.79,"profit":true},{"date":"2023-12-31","value":93.2,"profit":true}] |
Income Taxes | 59.00M | 72.50M | 107.20M | 114.70M | 122.30M | [{"date":"2019-12-31","value":48.24,"profit":true},{"date":"2020-12-31","value":59.28,"profit":true},{"date":"2021-12-31","value":87.65,"profit":true},{"date":"2022-12-31","value":93.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | 232.80M | 328.80M | 641.70M | 565.20M | 575.70M | [{"date":"2019-12-31","value":36.28,"profit":true},{"date":"2020-12-31","value":51.24,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":88.08,"profit":true},{"date":"2023-12-31","value":89.71,"profit":true}] |
Income From Continuous Operations | 232.80M | 328.80M | 641.70M | 565.20M | 593.40M | [{"date":"2019-12-31","value":36.28,"profit":true},{"date":"2020-12-31","value":51.24,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":88.08,"profit":true},{"date":"2023-12-31","value":92.47,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 241.70M | 346.20M | 661.80M | 585.90M | 593.40M | [{"date":"2019-12-31","value":36.52,"profit":true},{"date":"2020-12-31","value":52.31,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":88.53,"profit":true},{"date":"2023-12-31","value":89.66,"profit":true}] |
EPS (Diluted) | 3.24 | 4.75 | 8.61 | 8.57 | 8.08 | [{"date":"2019-12-31","value":37.63,"profit":true},{"date":"2020-12-31","value":55.17,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.54,"profit":true},{"date":"2023-12-31","value":93.84,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
WST | |
---|---|
Cash Ratio | 0.95 |
Current Ratio | 3.00 |
Quick Ratio | 2.23 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
WST | |
---|---|
ROA (LTM) | 10.00% |
ROE (LTM) | 17.78% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
WST | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.25 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.75 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
WST | |
---|---|
Trailing PE | 48.34 |
Forward PE | 44.05 |
P/S (TTM) | 8.19 |
P/B | 8.56 |
Price/FCF | 238 |
EV/R | 8.13 |
EV/Ebitda | 31.40 |
PEG | 6.07 |
West Pharmaceutical Services Inc (WST) share price today is $325.09
Yes, Indians can buy shares of West Pharmaceutical Services Inc (WST) on Vested. To buy West Pharmaceutical Services Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in WST stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of West Pharmaceutical Services Inc (WST) via the Vested app. You can start investing in West Pharmaceutical Services Inc (WST) with a minimum investment of $1.
You can invest in shares of West Pharmaceutical Services Inc (WST) via Vested in three simple steps:
The 52-week high price of West Pharmaceutical Services Inc (WST) is $412.94. The 52-week low price of West Pharmaceutical Services Inc (WST) is $264.65.
The price-to-earnings (P/E) ratio of West Pharmaceutical Services Inc (WST) is 48.3388
The price-to-book (P/B) ratio of West Pharmaceutical Services Inc (WST) is 8.56
The dividend yield of West Pharmaceutical Services Inc (WST) is 0.26%
The market capitalization of West Pharmaceutical Services Inc (WST) is $23.56B
The stock symbol (or ticker) of West Pharmaceutical Services Inc is WST